WEEK 32 · GATE 32: PAPER 3 PREPRINT (L4 CO-AUTHORED)
Do one thing. Then you are ahead.
The local guide signs the map. Paper 3 goes to bioRxiv with your co-author's name next to yours, and the case study goes public with your client's permission. These two artifacts together say something no certificate can: scientists trust my method, and companies pay for it. You also send a second audit or pilot proposal, because the best time to sell the second engagement is the week the first one becomes a story. …
If you only do one thing this week: the submission
Target journal author guidelines chosen with the partner
Saturday sandbox
Target journal author guidelines chosen with the partner (e.g., a protein engineering or applied microbiology journal; verify fit and open-access policy)
By Sunday you should be able to say: “I am a co-author with a scientist and a paid consultant with a public case study." --- # ACT VII · The lab's memory (weeks 33-35) > Act VII story. Every lab has a person everyone asks: "where is the protocol we used in March?", "who changed the buffer recipe?", "did we ever see this contamination before?". When that person goes on holiday, the lab loses its memory. Regulators have a stricter version of the same worry: in a GMP facility, if a record cannot show who did what, when, and why it changed, it legally did not happen. Act VII builds the archive and the librarian: documents extracted locally (nothing leaves the building), written into a real open-source electronic lab notebook with a tamper-evident audit trail, and a question-answering assistant that cites the exact paragraph and is measured against human-labelled answers. It is FermLit's method turned inward, onto a lab's own documents, and it is the on-prem argument that IP-sensitive biotech companies care about most”